COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT03468985
Brief Title: Nivolumab, Cabozantinib S-Malate, and Ipilimumab in Treating Patients With Recurrent Stage IV Non-small Cell Lung Cancer

First Submitted : March 13, 2018
First Submitted that Met QC Criteria : March 16, 2018
First Posted : March 19, 2018

Last Update Submitted that Met QC Criteria : June 20, 2020
Last Update Posted : June 23, 2020